Response to Comment on: Reyna et al. (2008) Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects. Diabetes 57:2595–2602

We thank Shapiro et al. (1) for their interest in our study (2) and their comment about the role of low-grade endotoxemia in the pathogenesis of insulin resistance in type 2 diabetic subjects. The notion that elevated levels of lipopolysaccharide (LPS) in the circulation derived from a gastrointestinal source could be responsible for the inflammatory state present in insulin-resistant subjects (3,4) is provocative and merits further investigation. Although caution is warranted when extrapolating from a small number of studies (3,4), in the future it would be useful to measure circulating LPS levels in insulin-resistant subjects and determine whether a correlation exists between the plasma LPS concentration and toll-like receptor (TLR)4 expression/signaling in tissue. As pointed out by Shapiro et al. (1), there is some evidence (obtained mostly in inflammatory cells) indicating that pre-exposure to LPS decreases the response to subsequent …

[1]  S Kumar,et al.  Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.

[2]  A. Medvedev,et al.  Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. , 2001, Journal of immunology.

[3]  A. Medvedev,et al.  Bacterial Lipopolysaccharide and IFN-γ Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-κB Activation1 , 2001, The Journal of Immunology.

[4]  R. DeFronzo,et al.  Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects , 2008, Diabetes.

[5]  P. Singer,et al.  Comment on: Reyna et al. (2008) Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects. Diabetes 57:2595–2602 , 2009, Diabetes.

[6]  H. Lithell,et al.  Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.

[7]  J. B. Kim,et al.  Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. , 2006, Biochemical and biophysical research communications.

[8]  S. Lydersen,et al.  Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. , 2006, The American journal of clinical nutrition.

[9]  M. Kiely,et al.  Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults , 2008, Diabetologia.

[10]  Xuetao Cao,et al.  Involvement of ERK, p38 and NF‐κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells , 2002, Immunology.

[11]  E. Kraegen,et al.  Fish oil prevents insulin resistance induced by high-fat feeding in rats. , 1987, Science.

[12]  F. Hu,et al.  Diet and risk of Type II diabetes: the role of types of fat and carbohydrate , 2001, Diabetologia.

[13]  J. Fernández-Real,et al.  Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. , 2006, Diabetes.

[14]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[15]  G. Fernandes,et al.  Biological effects of conjugated linoleic acids in health and disease. , 2006, The Journal of nutritional biochemistry.

[16]  P. Arner,et al.  Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity , 2004, Diabetologia.

[17]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.